P062 DOSE ESCALATION WITH ORIGINATOR INFLIXIMAB OR...

P062 DOSE ESCALATION WITH ORIGINATOR INFLIXIMAB OR COMBINATION THERAPY WITH ORIGINATOR INFLIXIMAB AND IMMUNOMODULATORS SIGNIFICANTLY INCREASES RISK FOR SERIOUS ADVERSE EVENTS IN PEDIATRIC IBD – THE DEVELOP EXPERIENCE

Veereman, Gigi, Busse, Christopher, Wang, Yanli, Izanec, James
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1053/j.gastro.2019.01.119
Date:
February, 2019
File:
PDF, 1.10 MB
english, 2019
Conversion to is in progress
Conversion to is failed